A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2019.1708901
Abstract: ABSTRACT Introduction: Histone deacetylase 6 (HDAC6) is unique in comparison with other zinc-dependent HDAC family members. An increasing amount of evidence from clinical and preclinical research demonstrates the potential of HDAC6 inhibition as an effective… read more here.
Keywords: hdac6 inhibitors; inhibitors neurodegenerative; 2014 2019; neurodegenerative diseases ... See more keywords